Only a subset of cancer patients currently benefit from personalized treatment approaches. Detection of actionable drug targets in cell-free DNA, more comprehensive molecular profiling integrating transcriptional analyses, and personalized combination regimens all hold promise in expanding the benefits of personalized oncology to larger numbers of cancer patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398581 | PMC |
| http://dx.doi.org/10.1016/j.ccell.2019.05.009 | DOI Listing |
Publication Analysis
Top Keywords
cancer patients
8
precision oncology
4
oncology three
4
three small
4
small steps
4
steps forward
4
forward subset
4
subset cancer
4
patients currently
4
currently benefit
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!